Veeva Systems (NYSE:VEEV – Get Free Report) is one of 93 public companies in the “Healthcare Technology” industry, but how does it weigh in compared to its competitors? We will compare Veeva Systems to related companies based on the strength of its earnings, risk, dividends, profitability, analyst recommendations, institutional ownership and valuation.
Volatility & Risk
Veeva Systems has a beta of 0.89, meaning that its share price is 11% less volatile than the S&P 500. Comparatively, Veeva Systems’ competitors have a beta of 1.11, meaning that their average share price is 11% more volatile than the S&P 500.
Valuation & Earnings
This table compares Veeva Systems and its competitors gross revenue, earnings per share (EPS) and valuation.
| Gross Revenue | Net Income | Price/Earnings Ratio | |
| Veeva Systems | $3.46 billion | $908.91 million | 49.65 |
| Veeva Systems Competitors | $350.65 million | -$24.15 million | 12.26 |
Veeva Systems has higher revenue and earnings than its competitors. Veeva Systems is trading at a higher price-to-earnings ratio than its competitors, indicating that it is currently more expensive than other companies in its industry.
Institutional & Insider Ownership
88.2% of Veeva Systems shares are held by institutional investors. Comparatively, 42.4% of shares of all “Healthcare Technology” companies are held by institutional investors. 10.6% of Veeva Systems shares are held by company insiders. Comparatively, 16.2% of shares of all “Healthcare Technology” companies are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock will outperform the market over the long term.
Profitability
This table compares Veeva Systems and its competitors’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| Veeva Systems | 29.34% | 14.25% | 11.71% |
| Veeva Systems Competitors | -749.77% | -28.38% | -15.05% |
Analyst Recommendations
This is a breakdown of current recommendations and price targets for Veeva Systems and its competitors, as reported by MarketBeat.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| Veeva Systems | 1 | 8 | 19 | 0 | 2.64 |
| Veeva Systems Competitors | 455 | 1537 | 2754 | 89 | 2.51 |
Veeva Systems presently has a consensus target price of $317.42, suggesting a potential upside of 5.15%. As a group, “Healthcare Technology” companies have a potential upside of 52.07%. Given Veeva Systems’ competitors higher probable upside, analysts clearly believe Veeva Systems has less favorable growth aspects than its competitors.
Summary
Veeva Systems beats its competitors on 9 of the 13 factors compared.
Veeva Systems Company Profile
Veeva Systems Inc. develops cloud-based software, data and consulting services for the life sciences industry. Its customers include pharmaceutical and biotechnology companies, medical device makers and contract research organizations. The company’s products support commercial operations as well as clinical, regulatory, quality and safety activities. Its offerings include Veeva Vault applications for managing documents and business processes, customer relationship management software, and data and analytics services.
Receive News & Ratings for Veeva Systems Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veeva Systems and related companies with MarketBeat.com's FREE daily email newsletter.
